Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

Conditions:   Lymphoblastic Leukemia, Acute, Adult;   Ph Negative ALL;   Newly Diagnosed Intervention:   Drug: Blinatumomab Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials